Cita APA

Mayfield, J. R., Czuchlewski, D. R., Gale, J. M., Matlawska-Wasowska, K., Vasef, M. A., Nickl, C., . . . Winter, S. S. (2016). Integration of Ruxolitinib into Dose-Intensified Therapy Targeted Against a Novel JAK2 F694L Mutation in B-precursor Acute Lymphoblastic Leukemia. Pediatr Blood Cancer.

Chicago Style Citation

Mayfield, Jodi R., David R. Czuchlewski, James M. Gale, Ksenia Matlawska-Wasowska, Mohammad A. Vasef, Christian Nickl, Gavin Pickett, Scott A. Ness, i Stuart S. Winter. "Integration of Ruxolitinib Into Dose-Intensified Therapy Targeted Against a Novel JAK2 F694L Mutation in B-precursor Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2016.

Cita MLA

Mayfield, Jodi R., et al. "Integration of Ruxolitinib Into Dose-Intensified Therapy Targeted Against a Novel JAK2 F694L Mutation in B-precursor Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2016.